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Rationale: End of test criteria can influence spirometry results. Epidemiology studies initiated
before adoption of the 1987 American Thoracic Society (ATS) guidelines typically used a 1 or 2 s
plateau on the volume-time curve, not a minimum test duration of 6 s, to terminate a test.
Objectives: To determine the effect of changing guidelines on FEV1, FVC and FEV1/FVC during
a longitudinal study of young adults.
Methods: Spirometry was performed on participants in the Coronary Artery Risk Development
in Young Adults (CARDIA) study. Values obtained at entry and 2, 5 and 10 years later using
accepted procedures were re-evaluated using the 2005 ATSeERS guidelines, which were in
effect for the year 20 exam. Generalized estimating equations were used to adjust tests with
short exhalations that were acceptable by then current end of test criteria.
Results: The percentage of participants at years 0, 2, 5, and 10 with exhalations less than 6 s
but with an acceptable plateau was 33%, 29%, 9%, and 2%, respectively. Exhalations less than
6 s occurred more frequently in younger and female participants, and were associated with
lower FVC and higher FEV1/FVC. For short exhalations the adjusted FVC was 47 ml and
110 ml higher than the measured FVC when 6 and 8 s exhalation times were used.
Conclusions: In longitudinal studies of young adults, changing end of test criteria may affect
lung function, especially among younger and female participants. Determining adjusted values
for tests with short exhalations may better represent the lung health of participants.
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Spirometry guidelines influence lung function 859Introduction MethodsObservational studies in which participants are followed
over time provide important information about the natural
history of disease including risk factors that contribute to
disease development and progression.1e3 During such
studies, measurement tools, assays, and guidelines for how
best to make the measurement of interest may change.
When measurement tools and assays change, comparability
studies are performed. However, changes in guidelines may
be problematic, especially if earlier measurements were
made using guidelines no longer considered acceptable.
In 1985e1986, 5115 individuals age 18e30 years were
enrolled in the longitudinal Coronary Artery Risk Develop-
ment in Young Adults (CARDIA) study to assess cardiovas-
cular risk factors in young adults.4,5 Spirometry was done at
the initial visit and at four subsequent visits. During the first
20 years of the study, guidelines for performing spirometry
changed. American Thoracic Society (ATS) guidelines pub-
lished in 1979 did not specify the duration of the forced
expiratory maneuver used to determine forced vital
capacity (FVC).6 These guidelines were used for the first 5
years of the CARDIA study. ATS guidelines published in 1987
specified a 2 s plateau and exhalation time of at least 6 s,7
but were not immediately incorporated into standard
practice. The most recent spirometry guidelines, jointly
developed by the ATS and European Respiratory Society
(ERS) and published in 2005,8 state that an acceptable test
in adults must have an exhalation time of at least 6 s, while
recognizing that this is not always possible.
Based on accepted practices at the time of each visit, the
CARDIA study’s manual of operations at years 0, 2 and 5
stated that expiration should be recorded to the plateau
(visual) and the plateau should be maintained for 1 s. The
year 10 manual of operations stated that the plateau should
be maintained for 2 s. At year 20 an acceptable test required
an exhalation time of at least 6 s and an acceptable plateau.
A possible effect of a short exhalation time and incomplete
plateau would be a lower FVC and an elevated FEV1/FVC not
truly representative of the individual’s lung health.
Because of previous concerns that end of test criteria
may influence spirometry results9 and a statistical proce-
dure performed on CARDIA data identified a secular trend
or methodological artifact that resulted in increasing mean
FVC, especially over the first 10 years,10 we re-examined
data from the first 10 years of CARDIA applying 2005 ATSe
ERS standards. We found that among participants at years
0 and 2 who had acceptable tests based on the manual of
operations then in use, approximately 30% had exhalation
times less than 6 s. Eliminating test results from earlier
years that did not meet current performance guidelines
would result in the loss of a large amount of valuable data
and possibly introduce bias. We therefore sought to
determine the prevalence of tests with short exhalations
that were otherwise acceptable at each examination,
identify participant characteristics associated with short
exhalation times, quantify the effect of the short exhala-
tion times on FEV1, FVC and FEV1/FVC, and provide guid-
ance to other investigators analyzing spirometry data from
tests performed before adopting the current end of test
criteria.Participants and measurements
The data are from CARDIA, a multi-center cohort study in
the United States.4,5 Participants were recruited from the
general population, randomly sampled from a prepaid
health plan in Oakland, CA and from populations in Bir-
mingham, AL, Chicago, IL, and Minneapolis, MN. At year 0,
the CARDIA study included 5115 participants in approxi-
mately equal number by ethnic group (black and white),
gender, ages (18e24 and 25e30), and education more than
or less than or equal to high school. The detailed methods,
instruments and quality control procedures are described in
previous reports.4,5
The analyses included all participants at each of the
examinations who had lung function testing and were not
pregnant. Demographic characteristics, lifestyle habits
(e.g., smoking history), and medical history were collected
by self-report using a questionnaire. An asthma diagnosis
was made at any examination if the participant had
a physician diagnosis of asthma or was taking asthma
medication.11
Lung function was measured at years 0, 2, 5, and 10
using a Collins Survey 8-l water sealed spirometer and an
Eagle II Microprocessor (Warren E. Collins, Inc., Braintree,
MA). Year 20 lung function was measured using a dry rolling-
seal volume OMI spirometer (Viasys Corp, Loma Linda, CA).
The accuracy of each spirometer was validated using
a Pulmonary Waveform Generator (MH Custom Design and
Manufacturing, Midvale, UT), a computer driven spirometry
simulator accurate to within 0.5%. The results obtained on
the OMI spirometers exceeded American Thoracic Society
(ATS) criteria for accuracy and precision.12 The four func-
tional Collins Survey spirometers used at the earlier visits
were also tested with the waveform generator. They too
exceeded ATS criteria for accuracy and precision. A study
comparing the Collins and OMI spirometers was performed
on 25 volunteers at the LDS Hospital (Salt Lake City, UT) and
demonstrated excellent consistency between the old and
new spirometers. The average difference between the
spirometers was 6  146 ml (mean  SD) for FVC and
21  135 ml for FEV1. The standard deviations were smaller
than the intra-session repeatability (150 ml) recommended
by the ATS/ERS.8
Standard quality control and testing procedures were
followed at all examinations.6e8 We analyzed the largest
FVC and FEV1 from at least five maneuvers. Data are rep-
resented as a percent of the predicted value.13 We only
used results from test sessions in which at least one
spirometry measurement met acceptability criteria at the
time of the test. Analyses were performed on data from
CARDIA participants who attended the initial (year 0) exam
and any of the subsequent exams.
Statistical methods
Body mass index was computed as weight (kg) divided by
height squared (m2). Smoking status was categorized into
three groups: never smoker, former smoker, current
smoker.
860 L.J. Smith et al.Factors associated with test sessions having short exha-
lation times, defined as no trial lasting 6 or more seconds
but that were acceptable based on the then current manual
of procedures, were assessed by univariate analysis using
Chi-square tests for categorical variables and t-tests or
ANOVA for continuous variables. Logistic regression was
used to assess multivariable associations.
To develop equations for adjusting the FVC value when
the exhalation time was less than 6 s but the test was
otherwise acceptable (e.g., there was an adequate
plateau), the year 0 pulmonary function dataset was
analyzed using each acceptable test. The 4549 participants
who underwent spirometry testing at baseline produced
30,690 records. Records were excluded if there was
evidence of airway obstruction (FEV1/FVC ratio <0.7), one
or more covariates (FEV1, height, age, exhalation time)
were missing, there was only one acceptable test, exhala-
tion times were less than 2 s or more than 8 s, or FVC values
were in the top and bottom 1 percent of test results. This
left 12,883 exhalations in 4412 participants available for
analysis. Most of the exclusions were because of missing
data.
The data were clustered within participant and
analyzed using Generalized Estimating Equations (GEE)14
with observed FVC in repeated trials as the dependent
variable. The GEE model correlated data from several
expiratory maneuvers performed by the same participant,
clustered within participant. We modeled the association
between spirometry values and exhalation time by
analyzing the same trial containing one or more exhala-
tions, rather than using the maximum FVC, FEV1 and
exhalation time coming from different trials. We strati-
fied by race and sex and used exhalation time, age, FEV1
and height as independent variables based on their high
statistical association with FVC. We calculated FVC for
both 6 and 8 s exhalation times in those with exhalation
times of 2e5 s. The calculated FVC values were
compared with the measured values and with the pre-
dicted values from the NHANES III equations developed by
Hankinson et al.11
Results
Participant characteristics
Study participant characteristics are shown in Table 1. At
entry, the average age was 24.9 years and participants
were evenly distributed by sex and race. The average body
mass index (BMI) was 24.6, nearly 60% were current or
former cigarette smokers, and the mean values for FVC,
FEV1 and FEV1/FVC were normal. Over 20 years the
percentage of female and white participants increased, the
BMI increased, and the proportion of current smokers
decreased while past and never smokers increased.
The percentage of participants with acceptable
spirometry tests based on the then current manual of
operations, but who did not have any exhalations lasting at
least 6 s at years 0, 2, 5, 10 and 20 was 33%, 29%, 9%, 2% and
1%, respectively (Fig. 1). The percentage of participants
with three or more acceptable tests lasting 6 s was 41%,
44%, 81%, 93% and 93% at the same times. As thepercentage of tests with exhalations lasting <6 s was very
low at years 10 and 20, the subsequent analyses were
limited to years 0, 2 and 5.
Participants with no exhalations lasting at least 6 s at
years 0, 2 and 5 were more likely to be younger, female,
and thinner than those with at least one exhalation 6 s
(Table 2). Those with no exhalations 6 s tests had
lower FVC values, but higher FEV1 and FEV1/FVC values.
The two groups did not differ by race, education level,
smoking status, or presence of current asthma. Multi-
variate analysis confirmed the association of female sex,
younger age, lower FVC and higher FEV1/FVC with short
exhalations.
The association between age and FVC at years 0 and 2
was examined in subjects who had one or more exhalations
lasting 6 s versus those who had none. An age cut-point
could not be identified below which individuals with no
exhalation times 6 s had FVC values comparable to those
with at least one exhalation 6 s (data not shown).
The association between exhalation time and FEV1 and
FVC was examined within each participant using the
generalized estimating equations model14 We found that
the FVC increased as exhalation time increased with
a plateau value being reached at 8 s (Fig. 2A; squares). The
correlation between exhalation time and FVC was 0.75. For
exhalation times between 3 and 8 s, each additional second
of exhalation time was associated with approximately a 1%
increase in FVC. These findings were similar when women
were analyzed separately (Fig. 2B). FEV1 was not influenced
by exhalation times between 2 and 8 s. However, those with
exhalation times longer than 8 s had lower FEV1 values
(Fig. 2A; diamonds).
We used generalized estimating equations (GEE) that
included measured FVC and FEV1, actual exhalation time,
age and height to adjust FVC values obtained from tests
with short exhalation times but were otherwise acceptable
(e.g., had the required plateau). The equations for the 4
race-sex groups are shown in Table 3. Using these equations
we calculated the FVC if an exhalation <6 s had been
prolonged to either 6 or 8 s. On average, the calculated FVC
was 1.2% (47  259 ml) and 2.7% (110  263 ml) higher than
the measured FVC when 6 and 8 s exhalation times were
used.
To gain additional insight into the factor(s) contributing
to the short exhalation times, we studied individuals with
no exhalations lasting 6 s at both years 0 and 5 (NZ 446)
and those with no exhalations 6 s at year 0 but at least
one exhalation 6 s at year 5 (NZ 1198) (Table 4). The two
groups did not differ by age or race, but those with short
exhalations at both years were more likely to be female and
thinner at year 5. The number of individuals with only short
exhalations decreased substantially over 5 years in the
absence of any change in test procedures.Discussion
Lung function measurements made before widespread
acceptance of the recent guidelines for determining the
acceptability of a forced vital capacity test had end of test
criteria that are different from those used today. The earlier
test results may not, therefore, be comparable to recent
Table 1 Participant characteristics.
Study year 0 (1985e1986) 2 (1987e1988) 5 (1990e1991) 10 (1995e1996) 20 (2005e2006)
Number 4549 4455 4257 3674 3416
Age e years
(mean  SD)
24.9  3.6 26.9  3.6 30.0  3.6 35.0  3.6 45.1  3.6
Males (%) 46.4 45.3 45.0 45.0 43.0
Raceewhite (%) 49.4 51.0 51.5 52.0 53.8
Education e high
school (%)
37.8 33.7 31.7 28.8 23.7*
BMI
(mean  SD)
24.6  5.0 25.2  5.3 26.2  5.9 27.5  6.6 29.4  7.0**
Smoking e current/
previous/never (%)
29.8/29.9/40.3 29.4/30.0/40.6 28.5/29.7/41.8 24.7/31.9/43.4 18.9*/36.2/44.9
FEV1 e % predicted
(mean  SD)
97.7  11.8 97.5  12.1 99.1  13.2 98.3  13.0 93.7  14.6**
FVC e % predicted
(mean  SD)
100.3  11.5 100.3  11.8 101.5  12.4 101.5  12.4 95.8  13.9**
FEV1/FVC
(mean  SD)
0.83  0.06 0.82  0.07 0.82  0.07 0.82  0.10 0.79  0.07**
Mean  SD unless otherwise noted.
The data are from individuals who underwent pulmonary function testing and had measurements of exhalation time available for
analysis.
*p < 0.05, **p < 0.001 compared to the baseline examination.
Spirometry guidelines influence lung function 861ones and changes seen over time may reflect differences in
test procedures rather than participant-specific, time-
dependent changes. Pistelli and colleagues previously
reported that end of test criteria can influence the FVC.9
However, the literatureprovides little guidanceabout how to
reconcile older and recent study results when testFigure 1 Association between examination year and the
percentage of participants with ‘‘unacceptably short’’ forced
vital capacity tests (all tests with exhalation time <6 s) based
on post-1987 ATS guidelines (diamonds) and with 3 or more
tests 6 s (squares).procedures change, norwhat participant characteristicsmay
influence the effects of different end of test criteria.
In our analysis of the CARDIA spirometry dataset, we
confirmed that end of test criteria influence spirometry
results. We also identified participants who were most
likely to have results influenced by previous end of test
criteria that did not require a minimum 6 s exhalation e
young adults, especially females. We believe these findings
have important implications for interpreting lung function
data from longitudinal studies begun 20 or more years ago
and which used end of test criteria that are not considered
acceptable today.
We initially thought the high proportion of tests with
exhalations less than 6 s during the first 5 years of the CARDIA
study was due to using a 1 s visual plateau as the end of test
criterion. Although this may have contributed, it does not
appear to be the sole factor as the same test procedureswere
followedat years 0, 2 and 5, duringwhich time theproportion
of tests with short exhalations decreased from 33% to 9%. We
also considered a training effect on either the staff or the
participants, but we believe this is unlikely because the time
between testing at years 0 and 2 was shorter than that
between years 2 and 5, while the percentage of tests with
short exhalations was unchanged between years 0 and 2 and
decreased bymore than 70% between years 2 and 5, Further,
the manual of operations, equipment, and training were
identical at all three times.
The spirometry guidelines published in 1979 by the
American Thoracic Society state that ‘‘End of test will
occur when the average flow over a 0.5 s interval is less
than 50 ml/s or when the volume change in a 0.5 s interval
is less than 25 ml’’.6 There is no mention of test duration.
Subsequent guidelines published in 1987 recommend: ‘‘an
obvious plateau in the volume-time curve resulting in no
change in volume for AT LEAST 2 s or an exhalation time of
at least 6 s’’.7 The 1994 ATS guidelines added: ‘‘There are
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Figure 2 Association between exhalation time and FVC
(squares) and FEV1 (diamonds) for all participants (A) and for
only the female participants (B) at year 0.
862 L.J. Smith et al.circumstances (e.g., the testing of children, young adults,
and some restricted patients) where shorter exhalation
times are acceptable.’’ However, neither these documents
nor the one published in 2005,8 which allows the tester to
use a plateau on the volume-time curve as an end of test
criterion, provide guidance on interpreting the results
obtained from tests with exhalation times less than 6 s. The
documents also do not discuss the possibility of adjusting
earlier FVC values in longitudinal epidemiology studies
when a test has a short exhalation time but is otherwise
acceptable.
To address this issue we analyzed all acceptable forced
expiratory maneuvers performed by participants at year
0 and found that the FVC increased with exhalation time up
to 8 s. We also found that those with exhalation times >8 s
had lower FEV1 values. In some subjects this may reflect the
presence of airflow obstruction not identified by a FEV1/
FVC < 0.70. Using the year 0 data, we developed equations
to estimate the FVC from acceptable tests (a plateau was
achieved and all other quality control parameters were
Table 3 Equations to adjust FVC values from tests with short exhalation times.
Group Estimated FVC (liters) as a function of exhalation time
White males 3.03480 þ 0.04490  exhalation time  0.00003  age þ 0.02634  height (cm) þ 0.78110  FEV1
White females 2.38537 þ 0.03321  exhalation time þ 0.00758  age þ 0.02019  height (cm) þ 0.78477  FEV1
Black males 2.24801 þ 0.04734  exhalation time þ 0.00373  age þ 0.01788  height (cm) þ 0.85956  FEV1
Black females 1.72559 þ 0.03177  exhalation time þ 0.00116  age þ 0.01523  height (cm) þ 0.83039  FEV1
The equations to calculate predicted FVC were developed using generalized estimating equations (GEEs) that included measured FVC,
FEV1, exhalation time, age and height. To calculate the adjusted FVC value for otherwise acceptable FVC tests with an exhalation time
of at least 2 s but less than 6 s, an exhalation time of 6 s or more is inserted in the above equations.
Spirometry guidelines influence lung function 863met) with exhalation times less than 6 s. The values
obtained using these equations with a projected exhalation
time of 8 s approximated the predicted values published by
Hankinson et al.13 We previously reported a trend in FVC
and FEV1 over spirometric examinations at years 0, 2, 5 and
10, based on a mathematical technique of looking at
differences in these measures in people of the same age
assessed at different examinations.15 We added 53 ml,
54 ml, and 16 ml to the predicted FVC at year 0, 2, and 5,
respectively.10 These adjustments are similar to those
obtained in the present study by examining the implications
of protocol differences between examinations.
It is possible that the association between longer exha-
lation times and larger FVC values was due to larger inha-
lation volumes, as reflected by the positive association
between FEV1 and FVC (Table 3). Alternatively, the asso-
ciation between a longer exhalation and larger FVC may be
due to instrument factors such as the greater likelihood of
inadvertent shaking of the tubing connecting the partici-
pant to the machine during the longer time. However, it is
unclear why either of these factors would have played
a greater role in the first 2 years of the study than in
subsequent years, especially during the 10 years in which
the same spirometers were used. It is also plausible that
the FEV1 is correct and the FVC somewhat small based on
failure to expel part of the residual air because of a shorter
exhalation time.
We are unable to explain why the participants in the
CARDIA study with short exhalations were younger andTable 4 Comparison of participants with all exhalation times
only at year 0.
Short exhalations Year 0 a
Number (% of total) 446 (10.
Age e years (at year 0) 24.0 
White (%) 227 (50.
Female (%) 309 (69.
BMI Y0: 22.5
Y5: 23.6
FEV1 e % predicted Y0: 99.3
Y5: 101
FVC e % predicted Y0: 91.8
Y5: 93.9
Mean  SD unless otherwise noted.
*p < 0.0001 compared to males.
**p < 0.05, # p < 0.0003, t p < 0.0001 compared to year 0.more likely to be female. However, anecdotal clinical
experience supports this observation. One consideration is
that early glottis closure occurs more frequently during
forced expiration in younger adults, especially young
women. Yet, as far as we know, there are no studies to
substantiate this possibility.
The FVC adjustment we propose has important impli-
cations for longitudinal assessment of lung function change
over time, especially in studies started more than 20 years
ago that used end of test criteria like those in the early
years of the CARDIA study. As these studies are an impor-
tant source of information about early life factors that
contribute to age- and time-dependent changes in lung
function, having the most accurate assessment of lung
function is vital to correctly interpreting the results.
Although one can debate the biological and clinical signif-
icance of the modest differences in FVC between the
measured values and the adjusted values obtained after
using the proposed equations (about 110 ml), this differ-
ence equals about 4 years of lung function decline in
healthy non-smokers13,16 and should be of interest to
researchers.
The strengths of this study include the large sample size,
excellent retention of participants, careful documentation
of the spirometry testing procedures, strict quality control
procedures, and use of the same equipment and many of
the same technicians during the first 10 years of the study.
Limitations include loss of 15% of the participants between
years 0 and 5, and the change in the characteristics of those< 6 seconds at both years 0 and 5 versus all < 6 seconds
nd year 5 Year 0 only
5%) 1198 (28.0%)
3.7 24.4  3.7
9%) 585 (48.8%)
7%)* 726 (60.6%)*
 4.1 Y0: 23.3  4.1
 4.8# Y5: 25.2  5.1t
 11.2 Y0: 98.6  11.5
.4  14.4** Y5: 99.4  12.4
 12.8 Y0: 94.7  12.8
 14.1** Y5: 96.9  13.7t
864 L.J. Smith et al.who remained in the study for the full 20 years. In addition,
the large standard deviations in the equations created to
adjust for short exhalations indicate they are best suited
for large epidemiology studies, not for clinical care.
In conclusion, analysis of the spirometry data from the
CARDIA study of young adults clearly demonstrates that
changing end of test criteria in a longitudinal study can
influence FVC and FEV1/FVC; younger adult and female
participants are most likely to be effected in studies that
used only a plateau on the volume-time curve to terminate
a test; equations using existing study data can be devel-
oped to adjust otherwise acceptable tests with short
exhalations from older studies; and these adjusted values
may better reflect the lung health of the participants.
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